Overview Financials News + Filings Key Docs Charts Ownership Insiders |
BankFinancial CORP (BFIN)
|
Add to portfolio |
|
|
Price: |
$10.71
| | Metrics |
OS: |
12.7
|
M
| |
|
|
Market cap: |
$136
|
M
| |
|
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
| |
|
|
BVPS
|
$12.00
| |
0.89
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 55.0 | 50.7 | 51.2 | 54.5 | 66.8 | 56.6 | 53.7 | 56.0 |
Revenue growth | 8.4% | -1.0% | -6.1% | -18.4% | 18.1% | 5.3% | -4.1% | 4.3% |
Cost of goods sold | 29.6 | 30.2 | 28.6 | 28.3 | 29.8 | 28.4 | 29.1 | 28.7 |
Gross profit | 25.4 | 20.5 | 22.6 | 26.2 | 37.0 | 28.2 | 24.6 | 27.3 |
Gross margin | 46.2% | 40.5% | 44.2% | 48.0% | 55.4% | 49.8% | 45.8% | 48.7% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 0.7 | 0.7 | 0.6 | 0.7 | 0.8 | 1.0 | 0.9 | 1.0 |
General and administrative | 6.3 | 6.0 | 5.9 | 5.9 | 4.2 | 4.1 | 4.3 | 4.3 |
EBITA | 18.5 | 13.8 | 15.9 | 19.5 | 31.6 | 22.7 | 19.5 | 22.1 |
EBITA margin | 33.6% | 27.1% | 31.1% | 35.8% | 47.3% | 40.2% | 36.2% | 39.4% |
Amortization of intangibles | | | | 0.1 | 0.2 | 0.5 | 0.5 | 0.6 |
EBIT | 18.5 | 13.8 | 15.9 | 19.5 | 31.4 | 22.2 | 19.0 | 21.5 |
EBIT margin | 33.6% | 27.1% | 31.1% | 35.7% | 47.0% | 39.3% | 35.3% | 38.4% |
Pre-tax income | 13.8 | 9.8 | 12.8 | 15.9 | 26.0 | 16.2 | 12.2 | 14.1 |
Income taxes | 3.3 | 2.3 | 3.6 | 4.2 | 6.7 | 7.2 | 4.7 | 5.4 |
Tax rate | 24.1% | 24.1% | 28.2% | 26.6% | 25.7% | 44.4% | 38.5% | 38.5% |
Net income | 10.5 | 7.4 | 9.2 | 11.7 | 19.3 | 9.0 | 7.5 | 8.7 |
Net margin | 19.1% | 14.6% | 17.9% | 21.4% | 29.0% | 15.9% | 14.0% | 15.5% |
|
Diluted EPS | $0.80 | $0.53 | $0.61 | $0.75 | $1.11 | $0.49 | $0.39 | $0.44 |
Shares outstanding (diluted) | 13.1 | 14.0 | 15.0 | 15.6 | 17.4 | 18.3 | 19.0 | 19.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|